Sustainability | 27 August 2026
Marksans Pharma receives ESG score of 56 from CRISIL for FY2026
The score was based on a voluntary review by CRISIL, using information available in the public domain
The score was based on a voluntary review by CRISIL, using information available in the public domain
The company's switch to briquettes as boiler fuel at select manufacturing sites contributed to an 18.6% reduction in Scope 1 emissions, while combined Scope 1 and Scope 2 emissions declined 8.8%
ESG rating agency independently prepared its assessment based on information about the company available in the public domain
The novel three-stage treatment system eliminates the need for energy-intensive sterilisation by using electric pulse technology, allowing water to be reused and biogas to be recovered
Implemented by SELCO Foundation, the initiative brings renewable energy-powered healthcare infrastructure and digital medical technologies to underserved communities
The initiative also aligned with the national campaign "Ek Ped Maa Ke Naam," symbolizing the nurturing bond between motherhood and nature
The company ranked 318th among 750 companies selected from more than 5,000 of the world’s largest and most influential organizations
Medical tourism platform commits to global sustainability, governance and transparency standards
The installation, with a capacity of 1,200 kWp, consists of 2,448 solar modules spread across approximately 6,200 m² of company land
The milestone, announced from Wilmington, Delaware, is powered through additional Renewable Energy Certificates (RECs) and backed by US-sourced renewable generation
Recognition places pharmaceutical excipients leader among the top 5% of companies globally, highlighting progress in emissions reduction, responsible sourcing, and sustainable supply chain practices
Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials
Phase I to supply clean energy to five facilities, with long-term plans to power 19 hospitals through a 30 MW renewable network
The Silver Medal recognizes strong performance across sustainability, ethics, environment, labour & human rights, and responsible procurement
Lupin attained a score of 91 out of 100, establishing itself as the leading pharmaceutical company globally
The program provides pharmaceutical manufacturers with auditable, primary emissions data and verified proof of a 30% CO? reduction across DFE Pharma’s lactose portfolio
Lupin’s double ‘A’ rating in Climate and Water exemplifies its steadfast commitment to sustainability
WuXi Biologics has integrated sustainability principles throughout its supplier lifecycle management
The company views ESG reporting as a strategic tool to build trust with clients, investors, regulators, and stakeholders worldwide
The company also reported significant progress toward its internally defined Sustainable Development Goals
Subscribe To Our Newsletter & Stay Updated
